Xencor (XNCR) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026)
Powered by 
Analysis
Xencor (XNCR) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -99.85% |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -5.07% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 1.70% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 10.87% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 19.14% |
| 10 | Xencor | 2.02 Bn | 1.64 Bn | - | -11.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.93% |
| Mar 31, 2026 | -12.44% |
| Dec 31, 2025 | -10.86% |
| Sep 30, 2025 | -12.52% |
| Jun 30, 2025 | -11.08% |
| Mar 31, 2025 | -7.45% |
| Dec 31, 2024 | -9.56% |
| Sep 30, 2024 | -8.28% |
| Jun 30, 2024 | -6.07% |
| Mar 31, 2024 | -4.72% |
| Dec 31, 2023 | 11.73% |
| Sep 30, 2023 | 33.30% |
| Jun 30, 2023 | 75.00% |
| Mar 31, 2023 | 134.72% |
| Dec 31, 2022 | 109.57% |
| Sep 30, 2022 | 111.09% |
| Jun 30, 2022 | 67.97% |
| Mar 31, 2022 | 27.40% |
| Dec 31, 2021 | 30.25% |
| Sep 30, 2021 | 22.30% |